IMNM - Immunome, Inc.

Over the past 90 days, insiders at Immunome, Inc. (IMNM) have been net sellers, shedding 132,752 shares worth roughly $3.5M on balance.

Classified under Biotechnology (Health Care sector), IMNM's insider flows are most useful compared with peers in the same group.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Siegall Clay B	870.7K	-	-
Dir	Wagenheim Philip	341.1K	$7.04M	-
CFO	Rosett Max	101.3K	-	-
Dir	Barchas Isaac	92.2K	$2.51M	-
Other	Tsai Philip	81.5K	-	-

Buys and sells only

10 filings · page 2

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jun 5, 2026	Bienaime Jean Jacques68	Director	Sell	10,500	$19.41	$203,820.00	-24.2%	+46.2%	-
Jun 5, 2026	Bienaime Jean Jacques68	Director	Buy	10,500	$19.45	$204,260.00	+31.9%	+46.2%	-
May 15, 2026	Bienaime Jean Jacques68	Director	Buy	5,000	$20.70	$103,500.00	+13.0%	+26.5%	-
Apr 2, 2026	Rosett Max65	Chief Financial Officer	Sale+OE10b5-1	65,000	$21.92	$1,424,916.08	-54.6%	-1.6%	-
Apr 2, 2026	Higgins Jack	Chief Scientific Officer	Sell10b5-1	9,438	$21.64	$204,238.32	-30.0%	-1.6%	-
Mar 27, 2026	Siegall Clay B77	President and CEO	Buy	25,450	$19.67	$500,601.50	+3.8%	-1.1%	-
Mar 23, 2026	Wagenheim Philip	Director	Sell	65,000	$20.55	$1,335,626.00	-16.0%	-7.6%	-
Mar 11, 2026	Bienaime Jean Jacques68	Director	Buy	2,000	$21.84	$43,670.00	+5.5%	-14.1%	-
Dec 30, 2025	Siegall Clay B77	President and CEO	Buy	4,729	$21.15	$100,018.35	+0.7%	-8.9%	-
Dec 22, 2025	Barchas Isaac56	Director	Sell10b5-1	383,200	$21.74	$8,330,079.62	-15.9%	-5.8%	-